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concern about what BATCO’s competitors
might be doing to their “low delivery ciga-
rettes” (that is, low machine measured tar
and nicotine yield cigarettes) in order to create
brand allegiance. Kilburn proposed that a
regular etorphine dose of as little as 0.2 µg per
day would be sufficient to create an addictive
craving for the source. He also claimed that
the required delivery of around 7 ng per ciga-
rette (or around half the delivery of ben-
zo[a]pyrene) would be analytically difficult to
measure.
Etorphine is a powerful drug with heroin-
like effects, which include respiratory failure
in the case of overdose. It may be more famil-
iar to readers as “elephant juice”—a veteri-
nary drug with such high potency that a tiny
quantity injected from a dart can immobilise
an elephant.
The dangers of etorphine to humans have
been dramatically demonstrated in accidents
during veterinary use, as there have been fatal
overdoses to veterinarians attempting to dart
large unruly animals. Reputedly, a mere
scratch from an etorphine dart has been
sufficient in some cases to provide a fatal
overdose. As a consequence of these fatalities,
veterinarians who are registered to use
etorphine must now have an assistant stand-
ing by with a dose of an etorphine antagonist
in hand.
These observations on the dangers of
etorphine underscore Green’s and Kilburn’s
essential point: very low concentrations of
certain psychoactive substances may be suffi-
cient to produce important effects, including
addiction. Fortunately, etorphine has become
much more readily detectable in recent years
than Green and Kilburn suggested was the
case in 1977, because forensic toxicologists
have put considerable effort into developing
highly sensitive detection methods. However,
in a world market with minimal regulation of
cigarette additives and limited testing capac-
ity outside the industry’s own laboratories, we
should remain concerned about what the
tobacco industry might be willing to do in
order to create “brand allegiance”.
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How to critique consultancy
reports?
The recent proposals for smoke-free legisla-
tion in many countries have spawned a multi-
tude of studies which attempt to predict the
financial impact of such legislation. As de-
scribed by Scollo et al1 in this issue of Tobacco
Control, many of these studies fail to achieve
basic quality standards and this is more likely
when the tobacco industry funds the study.
However, findings from such flawed studies
can influence policy makers and it is essential
that public health advocates have strategies to
counter their impact.
In Hong Kong in 2001, the government
proposed to make all workplaces, including
catering venues, smoke-free.2 A consultancy
report for the catering industry, funded by the
tobacco industry, was published shortly after
and concluded that the legislation would
cause catering industry revenues to drop by
10.6% leading to job losses. This report was
based on a survey of customers to catering
venues, self reported spend on eating and
drinking out, and self predicted changes in
the event that catering venues were made
smoke-free. Since the methods used were not
made clear in the report, we had to attempt to
validate or refute the report mainly by an
assessment of its findings. We found the
following questions useful:
(1) Was the sample used for the consult-
ant’s survey representative of the population
being studied (customers of catering venues)?
Since we could not determine if sample selec-
tion was done properly, we had to look at
sample characteristics. The prevalence of
smokers was much higher than in other
survey data indicating a bias in the sample.
(2) Did the consultant’s data, when
extrapolated/aggregated, agree with other
standard data sources—for example, govern-
ment statistics? Much of the basic data
collected by the consultants was not disclosed
in their report but, to make their case, they
had to present some—for example, average
weekly spends in the different types of cater-
ing venues. From these data we could
estimate (a) expected weekly revenue in the
catering industry, (b) approximate market
shares for the different types of venue, and (c)
weekly spend on eating out per household if
the consultant’s data were valid. Each of these
estimates was quite implausible when com-
pared with data from the census and other
government sources.
(3) Could the consultant’s findings be
reproduced to shed light on the methods
used? Using a new set of data based on
random sampling, we tried to recreate the
consultant’s findings by deliberately introduc-
ing biases and incorrect aggregations which
we suspected were present in the consultant’s
methods. In this way we were able to produce
an almost identical set of results from the new
data. On the other hand, when we analysed
the new data in an appropriate fashion, we
predicted a rise of 5% rather than a drop of
nearly 11% in catering revenues.
The best means of influencing policy on
smoke-free catering venues is to use objective
outcome measures and data collected both
before and after the intervention, as recom-
mended by Siegel and listed by Scollo et al.1
The study we were able to refute would have
failed Siegel’s quality criteria. However, since
much of the lobbying against smoke-free leg-
islation is done before such policies are put in
place, local objective, before and after data are
inevitably not available. In our case, present-
ing our rebuttal of the consultant’s findings
along with the evidence accumulated from
overseas studies that smoke-free policies do
not harm catering industry revenues, greatly
reduced the harm that the consultant’s report
could have done to the proposed legislative
process. Our approach may be helpful to
policy makers faced with a similar situation in
their own locality.
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Interest in nicotine replacement
therapy among pregnant
smokers
In the UK nicotine replacement therapy
(NRT) may now be considered for those preg-
nant women who cannot otherwise stop
smoking.1 However, very little research has
been carried out with NRT during pregnancy
and the level of interest in using NRT is not
known.2 This letter reports the results of a
survey to assess the level of interest in using
NRT among pregnant smokers.
Across a seven month period pregnant
smokers were identified using the patient
administration system of a large district gen-
eral hospital in south west London. Ethical
approval was obtained and participants gave
verbal consent via the telephone. Women
identified as smokers at their first antenatal
booking visit were telephoned within one
week of this visit and invited to take part in
the survey. The interview took place during
the initial telephone call or during a further
call within 48 hours of the initial call. All sta-
tistical tests were two tailed.
Demographic information was obtained
from patient records. All the women were
asked “Can I just check, are you still smoking
at the moment?” (“yes” or “no”). Those still
smoking were asked “About how many a day
would you say you are smoking at the
moment?”, and “Are you thinking at all about
stopping?” (“yes” or “no”). Those expressing
an interest in stopping were asked “Do you
think you might want to stop in the next
month, or might you prefer to try a bit later
on” and “Would you be interested in receiving
some help from the hospital with stopping?”
(“yes” or “no”). Women stating an interest in
receiving help were asked “Some forms of
nicotine replacement therapy (NRT) can now
be used by pregnant smokers who feel they
wouldn’t be able to stop without it. Would you
choose to use NRT to help you to stop
smoking?”(“yes” or “no”).
Of the 207 smokers interviewed (fig 1) the
large majority were not in professional/
managerial occupations (85.0%, 176/207),
were white (75.8%, 157/207), and attended
their first antenatal booking visit in the
hospital (66.7%, 138/207) rather than in the
community. The mean (SD) duration of preg-
nancy was 18.6 (5.6) weeks and the mean
(SD) reported number of cigarettes smoked
per day was 7.3 (6.1).
Of those women reporting that they were
thinking about stopping smoking 44.7% (67/
150) expressed an interest in using NRT.
Interest in NRT was higher among women
who reported smoking more cigarettes per
day (analysis of variance (ANOVA): F = 7.6,
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